These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2029098)

  • 21. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.
    Ahya R; Douglas JG; Watson HG
    Heart; 1998 Sep; 80(3):299-300. PubMed ID: 9875094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion-associated graft-versus-host disease in an immunocompetent patient following accidental injury.
    Kobayashi H; Kitano K; Kishi E; Hara K; Ishida F; Saito H; Ota M; Furuta S
    Am J Hematol; 1993 May; 43(1):51-3. PubMed ID: 8317463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors].
    Hovdenes J; Solheim BG
    Tidsskr Nor Laegeforen; 1995 May; 115(12):1499-501. PubMed ID: 7770854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-homozygous donors and transfusion-associated graft-versus-host disease.
    N Engl J Med; 1990 Apr; 322(14):1004-7. PubMed ID: 2314438
    [No Abstract]   [Full Text] [Related]  

  • 25. [Post-transfusion graft-versus-host disease].
    Takahashi K
    Rinsho Ketsueki; 1992 May; 33(5):582-6. PubMed ID: 1630009
    [No Abstract]   [Full Text] [Related]  

  • 26. Graft-versus-host disease in rhabdomyosarcoma following transfusion with nonirradiated blood products.
    Labotka RJ; Radvany R
    Med Pediatr Oncol; 1985; 13(2):101-4. PubMed ID: 3856732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion-associated graft-versus-host disease: do transfusions from second-degree relatives pose a greater risk than those from first-degree relatives?
    Kanter MH
    Transfusion; 1992 May; 32(4):323-7. PubMed ID: 1585436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem.
    Jawa RS; Young DH; Stothert JC; Kulaylat MN; Landmark JD
    J Intensive Care Med; 2015 Mar; 30(3):123-30. PubMed ID: 23792801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature.
    Spitzer TR; Cahill R; Cottler-Fox M; Treat J; Sacher R; Deeg HJ
    Cancer; 1990 Dec; 66(11):2346-9. PubMed ID: 2245390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intact survival with transfusion-associated graft-versus-host disease proved by human leukocyte antigen typing of lymphocytes in skin biopsy specimens.
    Hentschel R; Broecker EB; Kolde G; Frosch M; Friedrich W; Holzgreve W; Westphal E; Harms E
    J Pediatr; 1995 Jan; 126(1):61-4. PubMed ID: 7815227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion-associated graft-versus-host disease in immunocompetent patient: early diagnosis and therapy.
    Sakurai M; Moizumi Y; Uchida S; Imai Y; Tabayashi K
    Am J Hematol; 1998 May; 58(1):84-6. PubMed ID: 9590157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of transfusion-associated graft-versus-host disease.
    Yasukawa M; Shinozaki F; Hato T; Takada K; Ishii Y; Tamai T; Takamatsu H; Shiobara S; Yoshizaki K; Fujita S
    Br J Haematol; 1994 Apr; 86(4):831-6. PubMed ID: 7918080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfusion-associated graft-versus-host disease.
    Ortiz A; Caramelo C; Plaza JJ; Jiménez Díaz F
    N Engl J Med; 1991 Jan; 324(2):128-9. PubMed ID: 1984181
    [No Abstract]   [Full Text] [Related]  

  • 34. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.
    Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D
    Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplified fragment length polymorphism analysis in the evaluation of posttransfusion graft-versus-host disease in a child undergoing extracorporeal membrane oxygenation.
    DePalma L; Bahrami KR; Kapur S; Short BL; Luban NL
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):182-4. PubMed ID: 7913148
    [No Abstract]   [Full Text] [Related]  

  • 36. Transfusion associated GVHD.
    Sohi I; Jacob S
    Indian J Pediatr; 2005 Jun; 72(6):533-5. PubMed ID: 15985746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion associated graft versus host disease in immunocompetent patients. Report of two cases.
    Gebran N; Aoun JP; Aftimos G; Debahy N; Chamseddine N; Hakimeh N; Bahous J
    J Med Liban; 1999; 47(4):255-8. PubMed ID: 10641456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human graft-versus-host disease.
    Parkman R
    Immunodefic Rev; 1991; 2(4):253-64. PubMed ID: 2059433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspectives on transfusion-associated graft-versus-host disease.
    Jeter E
    Int J Artif Organs; 1994 Jan; 17(1):1-4. PubMed ID: 8188393
    [No Abstract]   [Full Text] [Related]  

  • 40. Transfusion associated graft versus host disease.
    Tipu HN; Ahmed TA; Khalilullah ; Ahmed S; Satti T; Ahmed P
    J Pak Med Assoc; 2008 Mar; 58(3):143-5. PubMed ID: 18517122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.